TriSalus Life Sciences, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 8.9M | 13.2M | 11.6M | 11.2M | 9.2M | 8.3M | 7.3M | 7.4M |
| Cost of Goods Sold | 1.2M | 1.8M | 1.9M | 1.8M | 1.5M | 1.2M | 1.0M | 912K |
| Gross Profit | 7.7M | 11.4M | 9.7M | 9.4M | 7.7M | 7.0M | 6.3M | 6.5M |
| R&D Expenses | 3.2M | 2.6M | 5.2M | 3.9M | 3.3M | 3.0M | 4.2M | 4.7M |
| Operating Expenses | 16.1M | 14.7M | 18.7M | 16.7M | 15.0M | 14.6M | 15.1M | 14.6M |
| Operating Income | -8.4M | -3.3M | -9.0M | -7.3M | -7.3M | -7.6M | -8.7M | -8.2M |
| Other Income / Gains | 10.0M | -6.5M | -1.8M | -959K | -3.0M | -2.5M | 6.3M | 3.8M |
| Net Income | 1.5M | -9.8M | -10.8M | -8.3M | -10.4M | -10.1M | -2.4M | -4.3M |
| EPS (Diluted) | 0.03 | -0.21 | -0.96 | -0.27 | -0.39 | -0.41 | -0.12 | -0.21 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.862 | 0.867 | 0.835 | 0.839 | 0.837 | 0.853 | 0.863 | 0.876 |
| General And Administrative Expenses | 5.5M | 4.2M | 6.7M | 5.7M | 5.0M | 4.7M | 4.7M | 4.0M |
| Selling And Marketing Expenses | 7.4M | 8.0M | 6.8M | 7.2M | 6.7M | 7.0M | 6.1M | 6.0M |
| Selling General And Administrative Expenses | 12.9M | 12.1M | 13.5M | 12.8M | 11.7M | 11.7M | 10.9M | 10.0M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 17.3M | 16.5M | 20.6M | 18.5M | 16.5M | 15.8M | 16.1M | 15.5M |
| Interest Income | 164K | 177K | 170K | 134K | 74K | 57K | 158K | 97K |
| Interest Expense | 1.4M | 1.5M | 1.5M | 1.4M | 1.2M | 1.1M | 1.1M | 877K |
| Depreciation And Amortization | 135K | 126K | 163K | 165K | 172K | 193K | 169K | 207K |
| Ebitda | 3.1M | -8.2M | -9.2M | -6.7M | -9.0M | -8.8M | -1.1M | -3.2M |
| Ebitdaratio | 0.35 | -0.619 | -0.794 | -0.598 | -0.981 | -1.071 | -0.148 | -0.44 |
| Operating Income Ratio | -0.945 | -0.248 | -0.779 | -0.654 | -0.799 | -0.918 | -1.189 | -1.11 |
| Income Before Tax | 1.5M | -9.8M | -10.8M | -8.3M | -10.4M | -10.1M | -2.4M | -4.3M |
| Income Before Tax Ratio | 0.173 | -0.739 | -0.934 | -0.739 | -1.131 | -1.224 | -0.327 | -0.587 |
| Income Tax Expense | 4K | 0 | 5K | -3K | 5K | -1K | -3K | 7K |
| Net Income Ratio | 0.173 | -0.739 | -0.935 | -0.739 | -1.132 | -1.224 | -0.326 | -0.588 |
| Epsdiluted | 0.03 | -0.21 | -0.96 | -0.27 | -0.39 | -0.41 | -0.12 | -0.21 |
| Weighted Average Shs Out | 51.5M | 46.8M | 43.1M | 32.9M | 28.5M | 26.5M | 26.5M | 23.9M |
| Weighted Average Shs Out Dil | 52.3M | 46.8M | 43.1M | 32.9M | 28.5M | 26.5M | 26.5M | 23.9M |